# Holmium-166 Retrospective Collection of Real-World Data

> **NCT05111795** · — · COMPLETED · sponsor: **Terumo Europe N.V.** · enrollment: 146 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Metastatic Cancer

## Interventions

- **DEVICE:** Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres

## Key facts

- **NCT ID:** NCT05111795
- **Lead sponsor:** Terumo Europe N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-17
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-04-08
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111795, "Holmium-166 Retrospective Collection of Real-World Data". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05111795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*